IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA

Human glioblastoma (hGBM) carries a dismal prognosis and inevitably relapses despite aggressive therapy. Many of the 14 members of the Eph receptor tyrosine kinase family are expressed in hGBM initiating cells (GICs) and constitute potential molecular targets. We hypothesize that multiple members of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Qazi, Maleeha, Vora, Parvez, Venugopal, Chitra, Gorelik, Maryna, Singh, Mohini, Hu, Amy, Subapanditha, Minomi, Chokshi, Chirayu, Savage, Neil, Yelle, Nicholas, Adams, Jarrett, Moffat, Jason, Sidhu, Sachdev, Singh, Sheila
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692371/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.462
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados